Laekna Administers First Dose of Weight Loss Drug in China During Phase I Clinical Trials; Shares Gain 6%
Laekna Administers First Dose of Weight Loss Drug in China During Phase I Clinical Trials; Shares Gain 6%
Laekna在中國進行了第一階段臨床試驗期間給予減肥藥的第一劑，股價上漲6%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊